Item 2.02 Results of Operations and Financial Condition. OnJanuary 13, 2022 , spokespersons ofViewRay, Inc. ("ViewRay" or the "Company") plan to present the information in the presentation attached hereto as Exhibit 99.1 to analysts and investors which will include its preliminary financial results for the fourth quarter and full fiscal year endedDecember 31, 2021 . The information in this Item 2.02 of this Current Report on Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), or incorporated by reference in any filing ofViewRay under the Securities Act or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. Item 7.01 Regulation FD Disclosure. Spokespersons ofViewRay plan to present the information in the presentation attached hereto as Exhibit 99.1 to analysts and investors from time to time on or afterJanuary 13, 2022 . The presentation will be available on the Investor Relations page at Company's website at: http://investors.viewray.com. The furnishing of the attached presentation is not an admission as to the materiality of any information therein. The information contained in the presentation is summary information that is intended to be considered in the context of more complete information included inViewRay's filings with theU.S. Securities and Exchange Commission (the "SEC") and other public announcements thatViewRay has made and may make from time to time by press release or otherwise.ViewRay undertakes no duty or obligation to update or revise the information contained in this report, although it may do so from time to time as its management believes is appropriate. Any such updating may be made through the filing of other reports or documents with theSEC , through press releases or through other public disclosures. For important information about forward looking statements, see the slide titled "Forward-Looking Statements & Disclaimer" in Exhibit 99.1 attached hereto. The information in this Item 7.01 of this Current Report on Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act, or incorporated by reference in any filing of the Company under the Securities Act or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 ViewRay J.P. Morgan Healthcare Conference Presentation. 104 Cover Page Interactive Data File (embedded
within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source